← Insider buys
NKTR

Nektar Therapeutics · Healthcare

Director Christopher A Kuebler sold $3.9M of Nektar Therapeutics

Sold$3,903,914
$97.60Price
40,000Shares
−50%Stake

What NKTR did after the filing

Prices for NKTR after this filing aren't in yet.

Traded Tue, Mar 6. Filed Thu, Mar 8, 1:10 PM ET, during the session. Not investment advice.